More than 115 million Americans have prediabetes, yet an estimated 80 percent don't know it. Now, new research is revealing that the risk of progressing to type 2 diabetes is far from uniform — especially among younger adults. A study presented at a recent medical conference found that among adults ages 18 to 40 with prediabetes, the likelihood of developing diabetes within five years varies widely depending on fasting glucose levels and other metabolic factors.
The study, reported by Healthline, analyzed data from 662 young adults with prediabetes drawn from three major U.S. cohorts, including the Framingham Heart Study and the Coronary Artery Risk Development in Young Adults study. Participants were followed for an average of seven years. Those with higher fasting glucose levels — particularly individuals who met existing FDA criteria for GLP-1 receptor agonist medications — faced significantly elevated risks of progressing to type 2 diabetes.
The researchers applied FDA prescribing criteria for GLP-1 drugs, which include a BMI of 30 or higher, or a BMI of 27 or higher combined with at least one weight-related condition such as high cholesterol or high blood pressure. By stratifying risk this way, they identified subgroups within the prediabetic population that might benefit most from earlier, more targeted interventions.
These findings challenge the one-size-fits-all approach to diabetes prevention. The research team argues that tailored strategies — rather than blanket recommendations — could do more to prevent the serious complications that accompany type 2 diabetes, including heart disease, kidney disease, and stroke. The study has not yet been published in a peer-reviewed journal.
Experts emphasize that screening remains critical, since prediabetes often produces no symptoms. Lifestyle changes such as improved diet, regular exercise, quality sleep, and stress management remain foundational tools for preventing or delaying the onset of type 2 diabetes, regardless of individual risk level.
